Results 311 to 320 of about 453,081 (334)
Some of the next articles are maybe not open access.
2022
COPD is a complex syndrome causing pulmonary and systemic effects. The main feature is airway obstruction and the most important clinical phenotypes are chronic bronchitis and emphysema. COPD is characterized by high prevalence worldwide, relevant mortality and significant socio-economic burden.
Murgia N. +3 more
openaire +3 more sources
COPD is a complex syndrome causing pulmonary and systemic effects. The main feature is airway obstruction and the most important clinical phenotypes are chronic bronchitis and emphysema. COPD is characterized by high prevalence worldwide, relevant mortality and significant socio-economic burden.
Murgia N. +3 more
openaire +3 more sources
COPD is not COPD is not ALLERGY [PDF]
Wiener klinische Wochenschrift, 2009 Chronic obstructive pulmonary disease (COPD) is still a poorly understood disease. Its pathogenesis is excitingly complex and has systemic consequences caused not only by increased production of certain cytokines but also by neurohumoral activation, chronic bacterial infection, muscle wasting and cachexia. Asthma and COPD have many overlapping clinical
openaire +2 more sources
COPD-Lite, COPD-Hard, or COPD-for-What?
American Journal of Respiratory and Critical Care Medicine, 2011not ...
de Marco R, Accordini S, Marcon A
openaire +2 more sources
Expertentreffen COPD: Exazerbation der COPD
Pneumologie, 2017Acute worsenings of chronic obstructive pulmonary disease (COPD) were for a long time regarded as transient deteriorations, although occasionally life-threatening. No connection to disease progression was recognized. Data emerging during the last decade showed that patients had a considerably worse survival outcome after severe exacerbations.
Lorenz, J. +10 more
openaire +4 more sources
Clinics in Chest Medicine, 2014
Chronic obstructive pulmonary disease (COPD) is currently defined as a common preventable and treatable disease that is characterized by persistent airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases.
Vestbo, Jorgen, Vestbo, Jørgen
openaire +4 more sources
Chronic obstructive pulmonary disease (COPD) is currently defined as a common preventable and treatable disease that is characterized by persistent airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases.
Vestbo, Jorgen, Vestbo, Jørgen
openaire +4 more sources
Nursing Standard, 2015
Essential facts Chronic obstructive pulmonary disease (COPD) covers a number of lung conditions, including emphysema and chronic bronchitis. People with COPD have lung damage that is not fully reversible. These conditions kill about 30,000 people a year in the UK.
openaire +2 more sources
Essential facts Chronic obstructive pulmonary disease (COPD) covers a number of lung conditions, including emphysema and chronic bronchitis. People with COPD have lung damage that is not fully reversible. These conditions kill about 30,000 people a year in the UK.
openaire +2 more sources
Wiener Medizinische Wochenschrift, 2005
Rehabilitation of COPD-patients is an important part of the therapeutic management. The effects of endurance- and resistance-training as well as respiratory muscle-training are evident. Smoking cessation therapy is standardized, effective and cheap, and is the prerequisite of a successful COPD management.
Alfred Lichtenschopf, Hartmut Zwick
openaire +3 more sources
Rehabilitation of COPD-patients is an important part of the therapeutic management. The effects of endurance- and resistance-training as well as respiratory muscle-training are evident. Smoking cessation therapy is standardized, effective and cheap, and is the prerequisite of a successful COPD management.
Alfred Lichtenschopf, Hartmut Zwick
openaire +3 more sources
COPD mortality - Is it all COPD?
5.2 Monitoring Airway Disease, 2015Background: We undertook a COPD mortality review in response to a mortality outlier alert within our trust due to a high COPD SHMI. Aims: This review aimed to elucidate the cause of the high SHMI, highlight diagnostic errors and identify necessary changes to our practice to improve patient care and outcomes.
Amarpreet Kaur +5 more
openaire +2 more sources
COPD or not COPD: Answer in FEV1
4.1 Clinical Physiology, Exercise and Functional Imaging, 2016Systematic screening of COPD allows identification of subjects with persistent airway obstruction who do not complain of any symptom. Little is known about subjects with undiagnosed persistent airway obstruction. We aimed to compare some clinical and spirometric data between subjects with spirometrically-defined COPD (i.e., persistent airway ...
Bruno Degano +11 more
openaire +2 more sources
Pulmonary Pharmacology & Therapeutics, 2010
Although there is increasing interest in using pulmonary biomarkers for a more complete and clinically relevant assessment of COPD and a plethora of biomarkers are becoming available, there is little information regarding their reproducibility and correlation with other outcome measurements in COPD.
CAZZOLA, MARIO, NOVELLI, GIUSEPPE
openaire +4 more sources
Although there is increasing interest in using pulmonary biomarkers for a more complete and clinically relevant assessment of COPD and a plethora of biomarkers are becoming available, there is little information regarding their reproducibility and correlation with other outcome measurements in COPD.
CAZZOLA, MARIO, NOVELLI, GIUSEPPE
openaire +4 more sources